ReviewInternational ophthalmology2025
Advances in machine learning for ABCA4-related retinopathy: segmentation and phenotyping.
Review in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Wavelet-Based Pattern ERG Biomarkers Outperform Temporal Amplitude Measures for Functional Stratification in Optic Nerve Disease.Translational vision science & technology · 2026Article
- Multidimensional Quantification of Macular Cone Activity in Pattern Electroretinography Using Discrete Wavelet Transform.Translational vision science & technology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeStargardt disease, also called ABCA4-related retinopathy (ABCA4R), is the most common form of juvenile-onset macular dystrophy and yet lacks an FDA approved treatment. Substantial progress has been made through landmark studies like that of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar), but tasks like image segmentation and phenotyping still pose major challenges in terms of monitoring disease progression and categorizing patient subgroups. Furthermore, these methods are subjective and laborious. Recent advancements in machine learning (ML) and deep learning show considerable promise in automating these processes.
methodsThis scoping review explores ML applications in ABCA4R, with a focus on segmentation and phenotyping. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) methodology, 15 articles were selected from 264, with 12 focused on the task of segmenting atrophic lesions, retinal flecks, retinal layer boundaries, or en-face imaging. Three studies addressed phenotyping based on electroretinography (ERG), visual acuity, and microperimetry.
resultsSeveral effective approaches were implemented in these studies, including ensemble modeling, self-attention mechanisms, soft-label approaches, and dynamic frameworks that consider extent of tissue damage. Excellent model performance includes segmentation DICE performances of 0.99 and ERG phenotyping accuracies 90% and greater. Smaller datasets and variable presentations present as significant challenges, while advanced methods like Monte Carlo dropout and active learning improve pipeline efficiency and performance.
conclusionML techniques are well on their way to automate key steps in ABCA4R evaluation with excellent performance. These emerging methods have the potential to expedite therapeutic innovation and enhance our understanding of ABCA4R.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.